Navigation Links
EmPower Research Launches Indian CRO Industry Report
Date:10/19/2007

NEW YORK, Oct. 20 /PRNewswire/ -- EmPower Research, LLC, a pioneer in the field of Business Research and Information Consulting, launched its first-ever study on the Indian Contract Research Organization (CRO) industry on Saturday.

The report titled 'Indian Contract Research Industry' (CRO-nicles) captures the industry's current position, trends, challenges and its outlook by speaking to the top line industry executives first hand.

India currently stands as one of the highest ranked emerging countries in global contract research in the pharmaceuticals industry followed by Italy and China, and is expected to grow by 20% compounded annual growth, over the next five years. Over 30 global top-ranking contract research organizations (CROs), including Quintiles and Kendle have set up centers in India.

Several major pharmaceutical companies are also setting up new centers, expanding their existing centers, or revisiting their India-centric strategies after a long time lapse. Today, as with every outsourced activity, clinical research has evolved as a major driver for the Indian CRO industry.

The key highlights of the report include an overview of the Indian clinical trials market, its size, and costs incurred, advantages and future outlook. The report examines the clinical trials market scenario, critical success factors driving the industry and key issues related to government regulations and governing clinical trials. In addition, the report also explores the outsourcing opportunities, industry dynamics and anticipated changes in the industry.

As part of the report, profiles of 27 major Indian CRO companies covering aspects like services offered, key people, clinical phases and financials for the last two years are also presented.

This report will be useful to Contract Research Organizations, pharmaceutical companies, venture capitalists (VCs) and leveraged buyout (LBO) firms, pharmaceutical educational institutions, research bo
'/>"/>

SOURCE EmPower Research, LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. New genital gel could empower women against the AIDS epidemic
2. Microbicides could serve to materialise women empowerment in the years to come
3. Europe: Empowering Society with Knowledge
4. Patients Empowered to Force for Better Services
5. New AMA Tool Empowers Doctors to Work Safer Hours
6. Diminishing Differences and Empowering Eves
7. Womens Empowerment Key to Curbing AIDS: UN
8. Kidney Stones - Interesting New Research implicates bacteria as its cause
9. Stem cell research- now Nobel Laureates join the debate
10. Researchers urge caution in using ear tube surgery
11. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...OWN, W.Va., Nov. 21 New...ng whether a smokeless, spitless tobacco product a...rchers have found that RJ Reynolds, Camel Snus - t...ction - contains surprisingly high levels of nicot... than most other snuff products," said Bruce Adkin...
(Date:11/21/2008)...A, S.C., Nov. 21 U.S. N...for Quality Assurance (NCQA) ranked BlueChoice(R) ...merica,s Best Health Plans(TM), published in U.S. ..., The respected annual ranking ranks the nation,...ber satisfaction and NCQA accreditation scores. NC...
(Date:11/21/2008)...E, N.J., Nov. 21 Barr Ph... that its shareholders overwhelmingly approved the...sition of Barr by Teva Pharmaceuticals Industries ...demonstrated the overwhelming support of the trans...wney, Barr,s Chairman and CEO. "We are pleased wit...
(Date:11/21/2008)...0 B.C., a new and deadly diseaseits cause remains ...state was teeming with citizens, soldiers and refu...rta. As streets filled with corpses, social order ... returned twice and Athens lost a third of its pop... marked the beginning of the end of the Golden Age...
Breaking Medicine News(10 mins):Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...therapeutic regimens are effective in suppressing ...nged treatment may be complicated by development o...spite // continued concerns over the safety of int... in clinical practice interrupt therapy for reason...
...te in vitro fertilization (IVF) baby of a single p...tions about the newborn's legal status and the sin... whose childless marriage had ended in divorce yea...ountry's first single father whose son was born th...
...obe University of Australia have found a new combi...he parasite responsible for causing malaria. They ...or treatment // helps in killing P. falciparum whi...hloroquine is a largely used drug in the treatment...
...most common breathing problems encountered by many...s been a considerable increase in the incidence of...as been estimated that nearly 196,000 children are...ry year with asthma attacks. A considerable amount...
Other Medicine News:Health News:A first for India - IVF baby born of surrogacy 2Health News:Improved parent-physician communication to prevent hospitalizations for childhood asthma 2
(Date:11/20/2008)..., Switzerland, November 20 /PRNewswire-FirstCall/ ...ti-infective Drugs Advisory Committee of the,U.S....o 2 against the,approval of intravenous iclaprim,...reatment of patients with complicated skin and ski...caused by methicillin-resistant Staphylococcus,au...
(Date:11/20/2008)... Calif., Nov. 20 Bionovo...ll present results from the Phase 1B,clinical tri...tatic breast,cancer, BZL101, at the Society for I...nce in Atlanta, Georgia. The Company,s oral prese...d will be presented as a part of the Best of the,...
(Date:11/20/2008)...Mass., Nov. 20 Radius Health ("Rad...onal $15 million to its second institutional finan...o $82.5 million and the total amount raised since ...sting institutional investors participated in the ...d including MPM Capital, The Wellcome Trust, Healt...
(Date:11/20/2008).... 20 PAREXEL Internation... biopharmaceutical services provider, today announ...provide regulatory consulting and clinical researc...ce, PAREXEL now has locations throughout five impo...which also include Argentina, Brazil, Chile, and M...
Breaking Medicine Technology:Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Mediterranean Diet May Ward Off Type 2 Diabetes 20660 1Mediterranean Diet May Ward Off Type 2 Diabetes 20660 2Mediterranean Diet May Ward Off Type 2 Diabetes 20660 3Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO 20657 1Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO 20657 2Technological Interventions Merge Into Health and Fitness 20654 1Technological Interventions Merge Into Health and Fitness 20654 2Technological Interventions Merge Into Health and Fitness 20654 3Brisk Walking Lowers Blood Pressure Increases Fitness in Obese 20651 1Brisk Walking Lowers Blood Pressure Increases Fitness in Obese 20651 2
...S WIRE)--Apr 26, 2007 - Northfield,Laboratories In...t,research organization has informed the Company t...l Phase III trauma trial with,PolyHeme(R), the Com...cell substitute, will not be complete until May., ...ories Inc. is a leader in developing an,oxygen-car...
... 0in 0pt; TEXT-ALIGN: left; tab-stops: 0in",align=...ops: list .5in; mso-list: l1 level1 lfo2">, <span ... MT,; mso-bidi-font-weight: bold">,Independent Jap...ng,Diovan to conventional therapy , , , ,<li st...so-list: l1 level1 lfo2">, <span style=,"FONT-SIZE...
Other Medicine Technology:Northfield Laboratories Investor Update 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 8Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 9Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 10Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 11Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 12
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: